Back

Effects of semaglutide on functional capacity in patients with type 2 diabetes and peripheral arterial disease: rationale and design of the STRIDE trial

27 August 2021 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Peripheral Vascular and Cerebrovascular Disease ePosters Pharmacotherapy ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Doctor Henrik Sillesen

Copenhagen University, Copenhagen (Denmark)

18 More presentations in this session

Presentation thumbnail
Impact of polyvascular disease on the prognosis of acute coronary syndrome
Professor N. Laraba (Algiers, DZ)
Abstract Slides
Presentation thumbnail
The efficacy and safety of dual-pathway inhibition therapy among patients with peripheral arterial disease - a meta-analysis
Doctor J. Mapili (Manila, PH)
Abstract Slides
Presentation thumbnail
Total thrombus-formation analysis system (T-TAS) can predict target lesion revascularization in patients undergoing endovascular therapy for critical limb ischemia
Doctor N. Kuyama (Osaka, JP)
Abstract Slides
Presentation thumbnail
Temporal course of vascular response after fluoropolymer paclitaxel-eluting stent implantation for femoropopliteal artery lesions
Doctor Y. Tomoi (Kitakyushu, JP)
Abstract Slides
Presentation thumbnail
Pre-dilatation prior to carotid artery stenting in very severe carotid artery stenosis: beneficial or detrimental?
Doctor M. Keskin (Istanbul, TR)
Abstract Slides

Access the full session

Session thumbnail
Peripheral Vascular and Cerebrovascular Disease ePosters

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources